ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

XNCR Xencor Inc

23,63
-0,30 (-1,25%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Xencor Inc XNCR NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,30 -1,25% 23,63 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
23,93 22,27 24,11 23,63 23,93
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.4.202414:01BWXencor Appoints Bart Cornelissen as Chief Financial Officer
11.3.202420:47EDGAR2Form 144 - Report of proposed sale of securities
11.3.202420:45EDGAR2Form 144 - Report of proposed sale of securities
11.3.202420:40EDGAR2Form 144 - Report of proposed sale of securities
11.3.202420:40EDGAR2Form 144 - Report of proposed sale of securities
07.3.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202420:39EDGAR2Form 144 - Report of proposed sale of securities
06.3.202414:32EDGAR2Form 8-K - Current report
05.3.202422:48EDGAR2Form 144 - Report of proposed sale of securities
05.3.202422:34EDGAR2Form 144 - Report of proposed sale of securities
05.3.202422:27EDGAR2Form 144 - Report of proposed sale of securities
28.2.202422:01BWXencor to Present at Upcoming Investor Conferences
27.2.202422:05EDGAR2Form 8-K - Current report
27.2.202422:01BWXencor Reports Fourth Quarter and Full Year 2023 Financial..
20.2.202422:31BWXencor to Host Webcast to Review Fourth Quarter and Full..
16.2.202423:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
16.2.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202400:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202420:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202422:07EDGAR2Form 144 - Report of proposed sale of securities
03.1.202422:01BWXencor to Present at the 42nd Annual J.P. Morgan Healthcare..
02.1.202414:01BWDane Leone Joins Xencor as Senior Vice President, Corporate..
29.12.202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202321:28EDGAR2Form 144 - Report of proposed sale of securities
21.11.202322:01BWXencor to Present at the Piper Sandler 35th Annual..
15.11.202322:02EDGAR2Form 8-K - Current report
07.11.202322:04EDGAR2Form 8-K - Current report
07.11.202322:03EDGAR2Form 8-K - Current report
07.11.202322:01BWXencor Reports Third Quarter 2023 Financial Results
03.11.202317:01BWXencor Presents Preclinical Data from Multiple XmAb®..
31.10.202321:01BWXencor to Host Third Quarter 2023 Financial Results Webcast..
26.10.202314:11EDGAR2Form 8-K - Current report
26.10.202314:01BWXencor Announces Planned Retirement of Chief Financial..
27.9.202315:01BWXencor to Present Multiple Posters at the SITC Annual..
19.9.202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.9.202322:31EDGAR2Form 8-K - Current report
19.9.202322:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
19.9.202322:01BWXencor Appoints Barbara J. Klencke, M.D., to Board of..
03.8.202323:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:02EDGAR2Form 8-K - Current report
03.8.202322:01BWXencor Reports Second Quarter 2023 Financial Results
27.7.202314:01BWXencor to Host Second Quarter 2023 Financial Results Webcast..
03.7.202313:16EDGAR2Form 8-K - Current report
31.5.202300:01BWXencor Presents Clinical Results from Phase 1a Study of..
08.5.202322:01BWXencor Reports First Quarter 2023 Financial Results

Kürzlich von Ihnen besucht

Delayed Upgrade Clock